The heterocyclic amine 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) targets multiple organs for tumorigenesis in the rat, including the colon and the skin. PhIP-induced skin tumors were subjected to mutation screening, which identified genetic changes in Hras (7/ 40, 17.5%) and Tp53 (2/40, 5%), but not in Ctnnb1, a commonly mutated gene in PhIP-induced colon tumors. Despite the absence of Ctnnb1 mutations, β-catenin was overexpressed in nuclear and plasma membrane fractions from PhIP-induced skin tumors, coinciding with loss of p120-catenin from the plasma membrane, and the appearance of multiple p120-catenin-associated bands in the nuclear extracts. Real-time RT-PCR revealed that p120-catenin isoforms 1 and 4 were upregulated in PhIP-induced skin tumors, whereas p120-catenin isoform 3 was expressed uniformly, compared with adjacent normal-looking tissue. In human epidermoid carcinoma and colon cancer cells, transient transfection of p120-catenin isoform 1A enhanced the viability and cell invasion index, whereas transient transfection of p120-catenin isoform 4A increased cell viability and cell proliferation. Knockdown of p120-catenin revealed a corresponding reduction in the expression of β-catenin and a transcriptionally regulated target, Ccnd1/Cyclin D1. Co-immunoprecipitation experiments identified associations of β-catenin with p120-catenin isoforms in PhIP-induced skin tumors and human cancer cell lines. The results are discussed in the context of therapeutic strategies that might target different p120-catenin isoforms, providing an avenue to circumvent constitutively active β-catenin arising via distinct mechanisms in skin and colon cancer.
interactions and signaling within the nucleus. 1 Cell adhesion and signaling functions have been defined for other AJ members, including β-catenin and E-cadherin. [6] [7] [8] [9] According to subcellular localization, p120-catenin can regulate the turnover of plasma membraneassociated cadherins and their protein partners, the activation of cytoplasmic small RhoGTPases, or transcriptional mechanisms within the nucleus. 1 Post-translational modifications and alternative splicing leads to the formation of multiple p120-catenin isoforms, with poorly characterized roles in physiology and pathophysiology. 1, 6 Loss of p120-catenin has been linked to chronic inflammation in the skin, resulting in atopic dermatitis. 10 Conditional targeting in mice showed that p120 null neonatal epidermis had reduced AJ components, and that as mice age, they displayed epidermal hyperplasia with chronic inflammation and skin tumor formation linked to NFκB activation. 11, 12 In humans, squamous cell carcinoma of the skin was associated with aberrant localization of p120-catenin. 13 Specifically, normal and benign tissues had p120-catenin in the cell-cell boundaries, whereas squamous cell carcinomas had p120-catenin localized away from the cell periphery, including p120-catenin isoforms 3A and 4. 13 p120-catenin and other members of the catenin family were commonly deregulated in human cutaneous melanoma. 14 In the heterocyclic amine-induced multi-organ rat carcinogenesis model, constitutive activation of β-catenin has been identified as a key driver of tumor formation in the colon. [15] [16] [17] [18] [19] [20] [21] The current investigation focused, for the first time, on the corresponding skin tumors induced in the rat by 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP).
In the absence of genetic changes in Ctnnb1, PhIP-induced skin tumors nonetheless exhibited high levels of β-catenin protein expression in the nucleus and plasma membrane. Subsequent work implicated a role for p120-catenin relocalization from the plasma membrane to the nucleus, and for specific p120-catenin isoforms influencing cell viability, proliferation, and invasiveness.
| MATERIALS AND METHODS

| Source of tumors
Forty skin tumors and adjacent normal-looking tissues were obtained from a 1-year carcinogenicity study in the rat. 17 A portion of each PhIP-induced skin tumor was processed for histopathology, as reported. 17 and the remainder was stored at −80°C for molecular analyses.
| Mutation screening
Gene targets were examined using the PCR-based single strand conformation polymorphism and direct sequencing methodology reported.
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| RNA expression
Frozen tumor samples and their matched normal tissues were extracted via the RNeasy kit (Qiagen, Valencia, CA), followed by cDNA synthesis using Superscript III (Invitrogen, Carlsbad, CA 
| Co-immunoprecipitation
Whole cell lysates from cell-based assays and from PhIP-induced skin tumors were subjected to co-immunoprecipitation (co-IP) assays, following the protocols reported elsewhere. [25] [26] [27] The antibodies listed above to p120-catenin and β-catenin were used to immunoprecipitate (IP) the corresponding endogenous protein, or transiently transfected p120-catenin isoforms, followed by immunoblotting (IB) of the reverse molecular target. In other experiments, whole cell lysates from PhIPinduced skin tumors and adjacent normal tissue were subjected to IP/ IB as in the cell-based assays. While optimizing the co-IP conditions, lysates from cell-based assays in which p120-catenin isoforms 1A, 3A, and 4A had been transiently transfected were used as reference for the position of each p120-catenin isoform in the gel (data not shown).
Results presented here were representative of the findings from two or more independent experiments.
| Cell viability
Cells (1 × 10 3 ) in 100 μl media were seeded in 96-well plates overnight and transfected with p120-catenin isoform 1A, 3A, 4A, or empty vector (as stated above). At selected times, 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added and formazan dye was assessed at 570 nm. 25 
| Cell invasion
Real-time invasion was monitored using the xCELLigence System (ACEA Biosciences Inc., San Diego, CA). Cells were transiently transfected with p120-catenin isoform 1A, 3A, 4A, or empty vector, and harvested at 72 h. Cells (10 5 ) in 100 μL serum-free media were loaded onto the upper chamber of CIM-Plate 16 pre-coated with 5%
Matrigel (BD Biosciences, San Jose, CA), and the lower chamber was filled with McCoy's 5A medium containing 10% FBS. Measurements were recorded at 10 min intervals for up to 16 h. 29 For each cell line and treatment condition, experiments were repeated at least three times.
| Cell proliferation
Cells were transfected with p120-catenin isoform 1A, 3A, 4A, or empty vector, and harvested at 72 h as described above. Before harvesting, cells were treated for 3 h with 10 μM bromodeoxyuridine (BrdU, Sigma-Aldrich). BrdU incorporation was assessed using the BrdU in situ detection kit (BD Biosciences), according to the manufacturer's instructions.
| Statistics
Data were expressed as mean ± SD and compared using the Student's t-test for paired samples, and analysis of variance (ANOVA, GraphPad Prism 5, La Jolla, CA) for group comparisons. Significant results were indicated in the figures as follows: *P < 0.05, **P < 0.01, ***P < 0.001.
Results shown in the figures were from replicate experiments that gave similar results, each repeated at least three times, unless indicated otherwise.
3 | RESULTS 3.1 | PhIP-induced skin tumors lack Ctnnb1 mutations but overexpress β-catenin
Ctnnb1 mutations were reported in heterocyclic amine-induced rat colon tumors, 15 and the same methodology was used to examine genetic changes in the corresponding PhIP-induced skin tumors.
Shifted bands were detected for Hras and Tp53, but not for Ctnnb1
( Fig. 1 ) or Ctnnd1 (data not shown). Sequencing confirmed the presence of a codon 174 mutation in Tp53, and codon 12 and codon 61 mutations in Hras (Table 1) . Final results indicated that the skin tumors had mutation frequencies of 7/40 (15.5%) in Hras, 2/40 (5%) in Tp53, and 0/40 (0%) in Ctnnb1 and Ctnnd1 (Table 2) .
Nuclear extracts from PhIP-induced skin tumors and adjacent normal tissues were subjected to immunoblotting ( were upregulated significantly in the skin tumors, as was Ctnnb1 (Fig. 2B ). When the corresponding plasma membrane-enriched fractions were immunoblotted (Fig. 3A) , increased expression of β-catenin and E-cadherin was detected in the skin tumors. In marked Table 1 ). (C) No shifted bands were detected for Ctnnb1 in skin tumors. Hatched box, positive control from a PhIPinduced rat colon tumor, in which the shifted band (solid arrow) was sequenced and confirmed to harbor a β-catenin mutation. 17 A random screening of non-shifted bands confirmed the wild-type status of Hras, Tp53, and Ctnnb1 in other skin tumor samples (data not shown) contrast, p120-catenin levels were reduced dramatically in the plasma membrane (Fig. 3A) , coinciding with multiple bands appearing in the nuclear extracts (Fig. 3B ). These findings suggested that, in the absence of Ctnnb1 mutation providing a driver for β-catenin overexpression, remodeling of AJ might redistribute β-catenin and p120-catenin to the nuclear compartment to affect transcriptional activity in the skin tumors.
| p120-catenin is overexpressed in different human skin cancer subtypes
Human tissue microarrays immunostained for p120-catenin protein revealed a general pattern of overexpression in squamous cell carcinoma, basal cell carcinoma, and malignant melanoma (Fig. 4) .
Focal areas of intense p120-catenin expression were detected in squamous cell carcinoma of the skin, whereas adjacent normal-looking tissue had moderate p120-catenin levels, largely restricted to the cell periphery (Fig. 4A) . Overexpression of p120-catenin in basal cell carcinoma, malignant melanoma, and lymph node metastases ( Fig. 4B-D) was recapitulated in human keratinocyte, melanoma, and epidermoid carcinoma cell lines (Fig. 4E-G) . Immunofluorescence staining detected p120-catenin not only in the cell periphery, but also in the cytoplasm and nucleus (Fig. 4H-K) . Interestingly, cells that stained strongly for p120-catenin in the cell periphery had less nuclear/cytoplasmic p120-catenin (Fig. 4H ), whereas cells with p120-catenin in the cytoplasm and nucleus tended to exhibit more restricted immunostaining of p120-catenin at the cell periphery. These observations are in accordance with findings from PhIP-induced skin tumors, implicating p120-catenin relocalization from AJ to the nucleus.
3.3 | p120-catenin isoforms 1 and 4 are upregulated in PhIP-induced skin tumors No significant differences were observed between skin tumors and the adjacent normal-looking tissue in the rat when Ctnnd1 mRNA levels were quantified under experimental conditions that did not discriminate between the different p120-catenin isoforms (data not shown). Subsequently, primers were designed to examine different isoforms of p120-catenin, arising from alternative start codons (Fig. 5A) . By conventional RT-PCR, isoform 3 was identified as the dominant p120-catenin transcript, being equally abundant in skin tumors and adjacent normal-looking tissues. On the other hand, in >90% of the PhIP-induced skin tumors examined, p120-catenin isoforms 1 and 4 were upregulated, compared to adjacent normallooking tissue (Fig. 5B, boxes) .
3.4 | p120-catenin isoforms differentially regulate the viability, proliferation, and invasiveness of cancer cells
Transient transfection studies were conducted with p120-catenin isoforms 1A, 3A, and 4A in human epidermoid carcinoma cells. At 72 h post-transfection, immunoblotting confirmed the increased levels of p120-catenin isoform 1A and 4A, relative to the vector control (Fig. 6A, boxes) . In A431NS cells, high constitutive levels of isoform 3A masked any changes from the corresponding transient transfection (Fig. 6A, oval) , although there was a noticeable reduction in cell viability due to exogenous isoform 3A (Fig. 6B) .
Interestingly, the opposite effect on cell viability was observed for p120-catenin isoform 1A and, in particular, isoform 4A (Fig. 6B) . A significant increase was detected in the number of cells staining positive for BrdU incorporation following transient transfection of p120-catenin isoform 4A, as compared with the other treatments (Fig. 6C) . In real-time cell invasion assays, p120-catenin isoform 1A
increased the slope significantly (Fig. 6D , dotted red line), indicating enhanced invasiveness, in contrast to isoforms 3A and 4A that had the same slope as the vector controls.
The latter experiments were repeated in SW480 colon cancer cells, which harbor high endogenous β-catenin due to a mutation in APC. 30 Forced expression of p120-catenin isoform 4A (Fig. 7A) resulted in a marked increase in cell viability compared with the vector controls (Fig. 7B ). Under these conditions, p120-catenin isoforms 1A
and 3A had a less dramatic effect on cell viability. In SW480 cells, a significant increase in the number of cells staining positive for BrdU incorporation was detected after transient transfection of p120-catenin isoform 4A (Fig. 7C) . In real-time invasion assays, p120-catenin isoform 1A increased the slope compared with the vector control, whereas p120-catenin isoforms 3A and 4A had the opposite effect (Fig. 7D) . The latter findings suggested reduced invasiveness of SW480 cells, which was not observed in A431NS cells transfected with p120-catenin isoforms 3A and 4A (Fig. 6D) . Differences in phenotypic response among cancer cell lines might be related, in part, to the endogenous levels of each p120-catenin isoform. 31 Nonetheless, the findings reaffirmed the opposing activities of some p120-catenin isoforms toward cell viability, proliferation, and invasiveness.
| p120-catenin/β-catenin interactions in cancer cells
Next, shRNA experiments were designed to knockdown p120-catenin in A431NS and SW480 cells. Immunoblotting confirmed the reduced expression of p120-catenin, and a corresponding lowering of β-catenin and Cyclin D1 protein levels (hatched boxes, Fig. 8A ), relative to mock and non-target shRNA controls. Under the same experimental conditions, qRT-PCR assays revealed a significant loss of Ccnd1 mRNA expression (Fig. 8B) , without changes in Ctnnb1 mRNA levels (data not shown). Given that Ccnd1 is a direct transcriptional target of β-catenin, 32 we postulated that reduced p120-catenin levels lowered the expression of β-catenin protein, and the loss of β-catenin transcriptionally downregulated Cyclin D1.
To examine protein-protein interactions involving p120-catenin and β-catenin, we took cell lysates from SW480 cells transiently transfected with different p120-catenin isoforms and performed co-IP assays (Fig. 8C) . Pulling-down with β-catenin in the IP step, followed by IB with p120-catenin, revealed a band corresponding to p120-catenin ) qRT-PCR analyses of selected β-catenin target genes normalized to glyceraldehyde-3-phosphate dehydrogenase (Gapdh); mean ± SD, n = 12, **P < 0.01, ***P < 0.001. Each panel is representative of an experiment that was repeated at least three times, for each gene mentioned, using twelve matched pairs of T/N samples Endogenous protein-protein interactions also were examined in untransfected A431NS cells (Fig. 8D) . Pulling-down with β-catenin antibody revealed interactions with p120-catenin isoforms 3A and 4A, plus a third putative p120-catenin isoform of intermediate size (open arrowhead, Fig. 8D ).
Finally, cell lysates from PhIP-induced skin tumors and adjacent normal-looking tissues were subjected to co-IP experiments. Compared with adjacent normal tissue, input controls from tumor lysates had high expression levels of p120-catenin isoforms 1A, 3A, and 4A
( Fig. 8E, arrowheads) . Pulling-down with β-catenin antibody in the tumor lysates revealed corresponding bands for p120-catenin isoforms 1A, 3A, and 4A in the IB step (Fig. 8E) , as well as the positive control, E-cadherin. We conclude that β-catenin can interact not only with E-cadherin, but also with p120-catenin isoforms 1A, 3A, and 4A in PhIP-induced skin tumors. Future studies might examine this possibility in more detail via tethering assays such as fluorescence resonance energy transfer.
| DISCUSSION
The colon and mammary gland are well-established primary target organs for tumorigenesis in PhIP-treated male and female rats, respectively, [33] [34] [35] but one-quarter to one-third of the animals also develop skin tumors. 17, 20 The skin tumors exhibit a diverse range of histopathology, including squamous adenoma, squamous papilloma, squamous cell carcinoma, basal cell carcinoma, and sebaceous epithelioma (Table 1) . These skin tumors, occasional Hras or Tp53 mutations, but lack genetic changes in Ctnnb1 (Table 2) . In marked contrast, c-myc, c-jun, and Ccnd1 gene activation is driven by Ctnnb1 mutations that stabilize β-catenin in PhIP-induced colon tumors. 15, 18, 37 We postulated that, rather than Ctnnb1 mutation leading to β-catenin protein stabilization, a key driver of skin tumorigenesis in the PhIP model might be the deregulation of AJ at the cell periphery, releasing β-catenin and p120-catenin to become active in other subcellular compartments. [38] [39] [40] [41] [42] [43] [44] It is known that p120-catenin binds to FIGURE 6 Effects of p120-catenin isoforms in human epidermoid carcinoma cells. (A) Transient transfection increased the levels of p120-catenin isoforms 1A and 4A (hatched boxes). Immunoblotting did not reveal a corresponding increase in p120-catenin isoform 3A (oval), possibly due to the high endogenous levels of this isoform in A431NS cells. Effects of p120-catenin isoforms were examined on (B) cell viability; at the 96 h time-point, p120-catenin isoforms 1A, 3A, and 4A were significantly different from the vector control (P < 0.05). (C) Bromodeoxyuridine (BrdU) incorporation, mean ± SD, n = 3; insert shows BrdU-positive cells, white arrows; (D) cell invasion assays, using realtime monitoring as reported by Parasramka et al 29 ; representative findings from at least three replicate experiments, each giving similar outcomes. The slope of the line for p120-catenin isoform 1A was significantly different from the other slopes shown, including the vector control, P < 0.05
Effects of p120-catenin isoforms in human colon cancer cells. (A) Transient transfection increased the levels of p120-catenin isoforms 1A, 3A, and 4A in SW480 cells. Effects of p120-catenin isoforms on (B) cell viability, at the 96 h time-point, p120-catenin isoform 4A was significantly different from the vector control (P < 0.05). (C) BrdU incorporation, and (D) cell invasion were as detailed in Fig. 6 , legend. Slopes of the p120-isoform treatments were each significantly different from the vector control, P < 0.05 the juxtamembrane domain of E-cadherin and stabilizes diverse cadherins at the cell membrane. 40 In SW48 colon cancer cells, a genetic deficiency in p120-catenin results in reduced E-cadherin protein expression, and restoring p120-catenin rescues the epithelial phenotype by stabilizing E-cadherin levels. 31 Interestingly, a "cadherin switch" has been described in the transition of normal melanocytes to malignant melanoma, which has features of epithelial-to-mesenchymal transition. 45 No loss of E-cadherin was detected in the current investigation; on the contrary, E-cadherin was consistently upregulated in PhIP-induced skin tumors (Fig. 3A) , implying that epithelialto-mesenchymal transition was not a major feature of skin tumorigenesis in this preclinical model.
In the current investigation, we observed that p120-catenin isoform 1 and isoform 4 were upregulated in PhIP-induced skin tumors, compared with adjacent normal tissue in the rat. Cell viability and invasion were enhanced by p120-catenin isoform 1A in A431NS cells, and a similar tendency was observed in SW480 cells, suggesting an oncogenic function. An oncogenic role also was ascribed to the shorter p120-catenin isoform, for the following reasons: (i) p120-catenin isoform 4 was transcriptionally upregulated in most of the PhIP-induced skin tumors (Fig. 5B) ; (ii) a band corresponding in size to isoform 4 appeared in the nuclear extracts of PhIP-induced skin tumors (Fig. 3B) ; (iii) in PhIP-induced skin tumors, co-IP experiments identified p120-catenin isoform 4A in association with β-catenin (Fig. 8E) In the present investigation, we were unable to associate specific genetic alterations, or changes in p120-catenin expression, to the corresponding histopathological diagnosis, due to the relatively limited number of forty PhIP-induced skin tumors available. Thus, despite the diverse range of histopathology ( however, we are cautious not to over-interpret the results as supporting reduced overall survival in cases of high versus low CTNND1 expression, given the small number of samples involved (Fig. 9 ).
Conditional targeting of p120-catenin in mice resulted in p120-catenin null neonatal epidermis that had reduced AJ components, and as mice age they displayed epidermal hyperplasia with chronic inflammation and skin tumor formation. 11, 12 In another mouse study, conditional knockout of p120-catenin led to the formation of preneoplastic and neoplastic lesions of the oral cavity, esophagus, and squamous forestomach, with tumors containing signficant immune cell infiltration. 47 These reports suggested that total ablation of 120-catenin significantly deregulates cell-cell communication and inflammation, resulting in enhanced tumor formation in the mouse.
However, the genetic models provided no specific insights into the opposing roles of different p120-catenin isoforms, and might have obscured crucial "stop/go" checkpoints relevant to human cancer development. In this context, the PhIP-induced skin carcinogenesis model offers certain advantages, [48] [49] [50] including the ability to examine p120-catenin isoforms at different stages of tumor formation, and the underlying mechanisms impacting cell survival, proliferation, and invasiveness.
